John E Levine, MD
- PROFESSOR | Medicine, Hematology and Medical Oncology
- PROFESSOR | Pediatrics
Specialties:Hematology-Oncology, Pediatric Hematology-Oncology
My clinical practice focuses exclusively on patients (both adult and pediatric) who undergo BMT and overlaps with my clinical research. I have designed, conducted, analyzed, and authored multiple clinical trials and data analyses of clinical GVHD, specifically, and clinical BMT, broadly. My long term goal is to improve outcomes for patients who undergo BMT by designing and conducting high impact clinical trials.
I co-direct the Mount Sinai Acute GVHD International Consortium [MAGIC] with Dr. James Ferrara. This international consortium provides the opportunity to develop and test innovative treatment approaches for allogeneic BMT patients.
Pediatric Hematology & Oncology
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- Adult Non-Hodgkin's Lymphoma
- Bone Marrow Transplantation
- Hematologic Malignancies
- Hematologic Malignancies, Pediatric
MD, Eastern Virginia Medical School
Residency, Pediatrics, Childrens Hospital of Los Angeles
Fellowship, Pediatric Hem/onc, Memorial Sloan-Kettering Cancer Center
Chair, Pediatric Scientific Interest Group, ASBMT Annual Meeting
Chair, Scientific Program, ASBMT Annual Meeting
Best Doctors in America
Ford Motor Company Leadership in Health Award
Immunosuppression, T Cells, Transplantation
My research focuses on clinical bone marrow transplantation. My primary research focus concentrates on clinical and translational studies for the diagnosis, prevention, and treatment of acute graft-versus-host disease (GVHD). In collaboration with the laboratory of James Ferrara, we developed and validated a GVHD plasma biomarker based scoring system that assigns patients to GVHD risk strata and can be used to determine treatment intensity.